GlassScriptPhysician profile
Yash Raval
NPI 1306465232
$4,958.40
in general payments reported to CMS, 2019-2025
16 companies · $3,453 in 2025
The $3,453 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $142 · 2023: $313 · 2024: $1,050 · 2025: $3,453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,534 · Travel and Lodging: $1,139 · Education: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,533.55 |
| Travel and Lodging | $1,139.27 |
| Education | $143.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,457.72 | 2024-2025 | Farapulse, Watchman Flx, Accolade Sr |
| Abbott Laboratories | $587.88 | 2024-2025 | Ensite, Mitraclip, Aveir |
| Shockwave Medical, INC | $267.78 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Actelion Pharmaceuticals US, INC. | $141.57 | 2024 | Opsumit, Uptravi |
| Astellas Pharma US INC | $88.90 | 2022 | |
| Abiomed | $63.41 | 2025 | |
| Novo Nordisk INC | $52.87 | 2022 | |
| Edwards Lifesciences Corporation | $48.21 | 2025 | Edwards Intuity Elite Valve System |
| Pfizer INC. | $42.51 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $42.14 | 2024 | |
| Cardiva Medical, INC. | $38.10 | 2023 | Cardiva Vascade 6/7f Vcs |
| Astrazeneca Pharmaceuticals LP | $29.62 | 2025 | Wainua |
| Atricure, INC. | $27.91 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.04 | 2023 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $23.09 | 2025 | Camzyos |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $21.65 | 2025 | Angio-Seal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yash Raval listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.